Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Colonization of the human gut by E. coli and colorectal cancer risk.

Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A.

Clin Cancer Res. 2014 Feb 15;20(4):859-67. doi: 10.1158/1078-0432.CCR-13-1343. Epub 2013 Dec 13.

2.

Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.

Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, de Vallée A, Déchelotte P, Darcha C, Pezet D, Bonnet R, Bringer MA, Darfeuille-Michaud A.

World J Gastroenterol. 2014 Jun 7;20(21):6560-72. doi: 10.3748/wjg.v20.i21.6560.

3.

High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.

Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R.

PLoS One. 2013;8(2):e56964. doi: 10.1371/journal.pone.0056964. Epub 2013 Feb 14.

4.

Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans.

Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ.

PLoS One. 2009;4(5):e5517. doi: 10.1371/journal.pone.0005517. Epub 2009 May 13.

5.

Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia.

Kohoutova D, Smajs D, Moravkova P, Cyrany J, Moravkova M, Forstlova M, Cihak M, Rejchrt S, Bures J.

BMC Infect Dis. 2014 Dec 24;14:733. doi: 10.1186/s12879-014-0733-7.

6.

Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation.

Martinez-Medina M, Denizot J, Dreux N, Robin F, Billard E, Bonnet R, Darfeuille-Michaud A, Barnich N.

Gut. 2014 Jan;63(1):116-24. doi: 10.1136/gutjnl-2012-304119. Epub 2013 Apr 18.

PMID:
23598352
7.

Association between intraepithelial Escherichia coli and colorectal cancer.

Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H.

Gastroenterology. 1998 Aug;115(2):281-6.

PMID:
9679033
8.

The gut microbiome modulates colon tumorigenesis.

Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, Schloss PD.

MBio. 2013 Nov 5;4(6):e00692-13. doi: 10.1128/mBio.00692-13.

9.

E. coli and colon cancer: is mutY a culprit?

Khan AA, Cash P.

Cancer Lett. 2013 Dec 1;341(2):127-31. doi: 10.1016/j.canlet.2013.08.003. Epub 2013 Aug 7. Review.

PMID:
23933175
10.

Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.

Malecka-Panas E, Kordek R, Biernat W, Tureaud J, Liberski PP, Majumdar AP.

Hepatogastroenterology. 1997 Mar-Apr;44(14):435-40.

PMID:
9164515
11.

Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.

Haag LM, Fischer A, Otto B, Plickert R, Kühl AA, Göbel UB, Bereswill S, Heimesaat MM.

PLoS One. 2012;7(5):e35988. doi: 10.1371/journal.pone.0035988. Epub 2012 May 1.

12.

Proliferative activity of normal and neoplastic colonic mucosa in population groups with high and low risk for colorectal carcinoma.

Jaskiewicz K, Lancaster E, Banach L, Karmolinski A.

Anticancer Res. 1998 Nov-Dec;18(6B):4641-4.

PMID:
9891533
13.
14.

Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration.

Spees AM, Wangdi T, Lopez CA, Kingsbury DD, Xavier MN, Winter SE, Tsolis RM, Bäumler AJ.

MBio. 2013 Jul 2;4(4). pii: e00430-13. doi: 10.1128/mBio.00430-13.

15.

The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.

Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, Platz EA, Pardoll DM, Sears CL.

Clin Infect Dis. 2015 Jan 15;60(2):208-15. doi: 10.1093/cid/ciu787. Epub 2014 Oct 9.

16.

Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.

Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C, Hall N, Rhodes JM, Campbell BJ.

Gut. 2014 May;63(5):761-70. doi: 10.1136/gutjnl-2013-304739. Epub 2013 Jul 11.

17.

Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers.

Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, Moris F, Rodrigo L, Mira A, Collado MC.

J Gastroenterol. 2015 Feb;50(2):167-79. doi: 10.1007/s00535-014-0963-x. Epub 2014 May 9.

PMID:
24811328
18.

DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas.

Jonsson C, Stål P, Sjöqvist U, Akerlund JE, Löfberg R, Möller L.

Mutagenesis. 2010 Sep;25(5):499-504. doi: 10.1093/mutage/geq033. Epub 2010 Jun 15.

19.

Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study.

Magdy A, Elhadidy M, Abd Ellatif ME, El Nakeeb A, Abdallah E, Thabet W, Youssef M, Khafagy W, Morshed M, Farid M.

Int J Surg. 2015 Jun;18:169-73. doi: 10.1016/j.ijsu.2015.04.077. Epub 2015 Apr 30.

PMID:
25937151
20.

Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, Huang T, Velcich A, Finlay BB, Chadee K, Vallance BA.

PLoS Pathog. 2010 May 13;6(5):e1000902. doi: 10.1371/journal.ppat.1000902.

Items per page

Supplemental Content

Write to the Help Desk